TALEN

TALEN1-myo1d

ID
ZDB-TALEN-181129-1
Name
TALEN1-myo1d
Previous Names
None
Target
Target Sequence 1
5' - ACCGTGCCATGAACATTT - 3'
Target Sequence 2
5' - CTGCCTTTGTACTGCTCAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
pt31a myo1d
pt31b myo1d
pt31c myo1d
Expression
Gene expression in Wild Types + TALEN1-myo1d
No data available
Phenotype
Phenotype resulting from TALEN1-myo1d
No data available
Phenotype of all Fish created by or utilizing TALEN1-myo1d
Phenotype Fish Conditions Figures
Kupffer's vesicle elliptic, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle decreased area, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle development decreased process quality, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
gut determination of digestive tract left/right asymmetry decreased occurrence, abnormal myo1dpt31a/pt31a standard conditions Fig. 2 with image from Saydmohammed et al., 2018
lateral plate mesoderm right side spaw expression mislocalised, abnormal myo1dpt31a/pt31a standard conditions Fig. 2 with image from Saydmohammed et al., 2018
Kupffer's vesicle dand5 expression spatial pattern, abnormal myo1dpt31a/pt31a standard conditions Fig. 2 with image from Saydmohammed et al., 2018
otic vesicle decreased area, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle malformed, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
heart heart looping decreased occurrence, abnormal myo1dpt31a/pt31a standard conditions Fig. 2 with image from Saydmohammed et al., 2018
Kupffer's vesicle epithelial cilium movement involved in determination of left/right asymmetry physical quality of a process, abnormal myo1dpt31a/pt31a standard conditions Fig. 2 with image from Saydmohammed et al., 2018
otic vesicle malformed, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
otic vesicle development decreased process quality, abnormal myo1dpt31a/pt31a standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle malformed, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle development decreased process quality, abnormal myo1dpt31a/pt31a; pt21Tg control Fig. 1 with imageFig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle elliptic, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 1 with image from Saydmohammed et al., 2018
otic vesicle decreased area, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle nucleus broken, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 4 with image from Saydmohammed et al., 2018
Kupffer's vesicle vacuole increased volume, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 3 with image from Saydmohammed et al., 2018
heart heart looping decreased occurrence, abnormal myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: forskolin, chemical treatment by environment: 3-isobutyl-1-methylxanthine Fig. 5 with image from Saydmohammed et al., 2018
heart heart looping decreased occurrence, abnormal myo1dpt31a/pt31a; pt21Tg control Fig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle development decreased process quality, exacerbated myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: ouabain Fig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle decreased area, abnormal myo1dpt31a/pt31a; pt21Tg control Fig. 1 with imageFig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle development process quality, ameliorated myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: forskolin, chemical treatment by environment: 3-isobutyl-1-methylxanthine Fig. 5 with image from Saydmohammed et al., 2018
heart heart looping decreased occurrence, abnormal myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: ouabain Fig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle posterior region has extra parts of type Kupffer's vesicle vacuole, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 3 with image from Saydmohammed et al., 2018
Kupffer's vesicle area, ameliorated myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: forskolin, chemical treatment by environment: 3-isobutyl-1-methylxanthine Fig. 5 with image from Saydmohammed et al., 2018
otic vesicle malformed, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Kupffer's vesicle decreased area, exacerbated myo1dpt31a/pt31a; pt21Tg chemical treatment by environment: ouabain Fig. 5 with image from Saydmohammed et al., 2018
Kupffer's vesicle epithelial cell morphogenesis process quality, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 3 with image from Saydmohammed et al., 2018
Kupffer's vesicle epithelial cell columnar, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 3 with image from Saydmohammed et al., 2018
Kupffer's vesicle vacuolar transport decreased rate, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 3 with image from Saydmohammed et al., 2018
otic vesicle development decreased process quality, abnormal myo1dpt31a/pt31a; pt21Tg standard conditions Fig. 1 with image from Saydmohammed et al., 2018
Citations